Insider trades

Michael S. Perry, Director of Arrowhead Pharmaceuticals ARWR, has filed 0 purchases and 1 sale on the open market. Over the past 12 months that comes to a net sale of $991.7K. The latest trade was on 25/12/16.

Michael S. Perry

Director
First filing
23/01/11
Trades
6 trades
Buys / sales
0 / 1
12-month net buying
−$991.7K
Last trade
25/12/16

Trading activity

Transactions

Trade type
Open-market sale25/12/0525/12/0916,250 sh$61.03$991,737.5−12.4%